H
HMNC Brain Health
The company is developing therapeutics for the treatment of neuropsychiatric disorders with a focus on depression. These are to consist of patented genetic tests, licensed drugs and companion…
About HMNC Brain Health
HMNC Brain Health is a clinical-stage biopharmaceutical company focused on pioneering precision psychiatry. The company leverages advanced AI and deep genomic insights to develop targeted therapies for mental health disorders. Operating in the biopharma sector, HMNC Brain Health serves patients with unmet medical needs, aiming to provide superior therapeutic outcomes. The business model revolves around research and development of innovative treatments, which are then brought to market through clinical trials and partnerships with healthcare providers. Revenue is generated through the commercialization of these therapies and potential collaborations with other pharmaceutical companies.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2010
- Headquarters
- Munich, Germany
- Employees
- 27
- Open positions
- 1
- Dealroom signal
- 45.6/100
- Industry
- Health
- Sector
- Health, Psychology, Core AI, Health Diagnostics, Hard Tech, AI Applications, Health It
- Technology
- Artificial Intelligence
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning HMNC Brain Health.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Jun 2026 | $50M | $200M | Undisclosed | ↗ |
| LATE VCOther financing | Apr 2025 | $0 | — | MM Vermögensverwaltungs · Aquarium Vermögensverwaltung · Five Star Capital · Trapp Investment Partners | — |
Growth signals
Latest recorded traffic for HMNC Brain Health is 1.3K monthly website visits, down 56.7% over the last three months. HMNC Brain Health's team grew 22.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Incommerce- CICircum
Series A7 investors entered at this stage
Carsten Maschmeyer
Guntard Gutmann
Toni Kroos- JGJahr Group
Josef Ackermann- WBWilhelm Beier
- HKHans Kompernaß
Series B and later5 investors entered at this stage
- MVMM Vermögensverwaltungs
- AVAquarium Vermögensverwaltung
- FCFive Star Capital
- TPTrapp Investment Partners
- JAJahr Assetmanagement
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about HMNC Brain Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See HMNC Brain Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







